Boston Trust Walden’s Synopsys SNPS Stock Holding History
Bought
Maintained
Sold
Other funds holding SNPS
ATO
LWCFA
VNIM
Boston Trust Walden's SNPS Position: Q2 2026 in Review
Boston Trust Walden reduced its Synopsys (SNPS) stake by 3.8% in Q2 2026, selling an estimated $13.2K and leaving 715 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #364.
Boston Trust Walden first reported a position in SNPS in Q1 2021 and has held it in 22 quarters since. The position peaked at $12.3M in Q4 2021. 508 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.
- Boston Trust Walden held 715 shares of Synopsys worth $319K as of Q2 2026.
- Boston Trust Walden sold 28 Synopsys shares in Q2 2026, an estimated $13.2K.
- Synopsys made up ﹤0.01% of Boston Trust Walden's portfolio in Q2 2026, its #364 holding.
- Boston Trust Walden first reported a position in Synopsys in Q1 2021 and has held it in 22 quarters since.
- Boston Trust Walden's Synopsys position peaked at $12.3M in Q4 2021.
- 508 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.
Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.